% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Collij:274065,
author = {Collij, Lyduine E and Bischof, Gérard N and Altomare,
Daniele and Bader, Ilse and Battle, Mark and Vállez
García, David and Lopes Alves, Isadora and Wolz, Robin and
Gismondi, Rossella and Stephens, Andrew and Walker, Zuzana
and Scheltens, Philip and Nordberg, Agneta and Gispert, Juan
Domingo and Drzezga, Alexander and Perissinotti, Andrés and
Morbelli, Silvia and Buckley, Christopher and Garibotto,
Valentina and Frisoni, Giovanni B and Farrar, Gill and
Barkhof, Frederik},
collaboration = {Consortium, AMYPAD},
title = {{Q}uantification {S}upports {A}myloid {PET} {V}isual
{A}ssessment of {C}hallenging {C}ases: {R}esults from the
{AMYPAD} {D}iagnostic and {P}atient {M}anagement {S}tudy.},
journal = {Journal of nuclear medicine},
volume = {66},
number = {1},
issn = {0097-9058},
address = {New York, NY},
publisher = {Soc.},
reportid = {DZNE-2025-00046},
pages = {110 - 116},
year = {2025},
abstract = {Several studies have demonstrated strong agreement between
routine clinical visual assessment and quantification,
suggesting that quantification approaches could support
assessment by less experienced readers or in challenging
cases. However, all studies to date have implemented a
retrospective case collection, and challenging cases were
generally underrepresented. Methods: We included all
participants (n = 741) from the AMYPAD diagnostic and
patient management study with available baseline amyloid PET
quantification. Quantification was done with the PET-only
AmyPype pipeline, providing global Centiloid and regional z
scores. Visual assessment was performed by local readers for
the entire cohort. From the total cohort, we selected a
subsample of 85 cases for which the amyloid status based on
the local reader's visual assessment and the Centiloid
classification (cutoff = 21) was discordant or that were
assessed with low confidence (i.e., ≤3 on a 5-point scale)
by the local reader. In addition, concordant negative (n =
8) and positive (n = 8) scans across tracers were selected.
In this sample (n = 101 cases; [18F]flutemetamol, n = 48;
[18F]florbetaben, n = 53), the visual assessments and
corresponding confidence by 5 certified independent central
readers were captured before and after disclosure of the
quantification results. Results: For the whole AMYPAD
diagnostic and patient management study cohort, overall
assessment by local readers highly agreed with Centiloid
status (κ = 0.85, $92.3\%$ agreement). This was
consistently observed within disease stages (subjective
cognitive decline-plus, κ = 0.82, $92.3\%$ agreement; mild
cognitive impairment, κ = 0.80, $89.8\%$ agreement;
dementia, κ = 0.87, $94.6\%$ agreement). Across all central
reader assessments in the challenging subsample,
quantification of global Centiloid and regional z scores was
considered supportive of visual reads in $70.3\%$ and
$49.3\%$ of assessments, respectively. After disclosure of
the quantitative results, we observed improvement in
concordance across the 5 readers (baseline κ = 0.65,
$65.3\%$ agreement; κ after disclosure = 0.74, $73.3\%$
agreement) and a significant increase in reader confidence
(baseline mean (M) = 4.0 vs. M after disclosure = 4.34,
Wilcoxon statistic (W) = 101,056, P < 0.001). Conclusion: In
this clinical study enriched for challenging amyloid PET
cases, we demonstrate the value of quantification to support
visual assessment. After disclosure, both interreader
agreement and confidence showed significant improvement.
These results are important considering the arrival of
antiamyloid therapies, which used the Centiloid metric for
trial inclusion and target engagement. Moreover,
quantification could support determination of amyloid-β
status with high certainty, an important factor for
treatment initiation.},
keywords = {Humans / Positron-Emission Tomography / Male / Female /
Aged / Amyloid: metabolism / Retrospective Studies /
Alzheimer Disease: diagnostic imaging / Middle Aged / Image
Processing, Computer-Assisted / Alzheimer (Other) /
Centiloid quantification (Other) / amyloid PET (Other) /
molecular imaging (Other) / neurology (Other) / visual read
(Other) / Amyloid (NLM Chemicals)},
cin = {AG Boecker},
ddc = {610},
cid = {I:(DE-2719)1011202},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:39542700},
pmc = {pmc:PMC11705786},
doi = {10.2967/jnumed.124.268119},
url = {https://pub.dzne.de/record/274065},
}